Neurology News

The use of machine learning models identified three distinct subtypes of Parkinson’s disease, which “could have immediate implications” in detecting clinical outcomes, researchers reported in NPJ Parkinson’s Disease.

Psychological distress symptoms were significantly associated with increased risk for all-cause dementia, researchers reported in JAMA Network Open.

The annual incidence of Parkinson’s disease among adults aged 65 years and older is 50% higher than previous estimates of 60,000 diagnoses annually, researchers reported in NPJ Parkinson’s Disease.

A sensational (or lack thereof) series on the signs and symptoms of the spellbinding sensory ganglionopathies.

Avidity Biosciences Inc. announced positive data from a phase 1/2 trial, which successfully delivered RNA into muscle for the first time in a study that aimed to treat patients with myotonic dystrophy, the company said in a press release.

Use of a genetic risk test for patients considering immunosuppressive therapies associated with development of progressive multifocal leukoencephalopathy may help reduce incidence of disease, researchers reported in Frontiers in Neurology.

Through the end of September, the S&P 500 had declined three consecutive quarters and lost nearly 24% of its value.

An estimated 55.8 million patients presented to U.S. emergency departments from 2016 to 2019 with a neurological complaint as the primary reason for their visit, researchers reported in JAMA Neurology.

A higher locus of control at work and home was associated with reduced psychosocial stress and lower odds of acute stroke, researchers reported in JAMA Network Open.

Imbrium Therapeutics LP, a subsidiary of Purdue Pharma LP, announced positive preliminary results from a phase 2 study of an investigational oral treatment for patients with insomnia during recovery from an alcohol use disorder.